Adverse effects of<unk>  include headache, nausea, dizziness, and limb pain.<unk>  has a theoretical risk of osteosarcoma, which was found in rat studies but not confirmed in humans. This may be because, unlike humans, rat bones grow for their entire life. The tumors found in the rat studies were located on the end of the bones which grew after the injections began. After nine years on the market, there were only two cases of osteosarcoma reported. This risk was considered by the FDA as "extremely rare" (1 in 100,000 people) and is only slightly more than the incidence in the population over 60 years old (0.4 in 100,000).
Teriparatide
Denosumab
Bolazine capronate
Zoledronic acid
Medronic acid
Alendronic acid
Risedronic acid
Ibandronic acid